Hibberd Catherine S, Quan Gerald M Y
Department of Surgery, Spinal Biology Research Laboratory, University of Melbourne, Austin Health, Heidelberg, VIC 3084, Australia.
Department of Spinal Surgery and Department of Orthopaedic Surgery, Austin Health, Heidelberg, VIC 3084, Australia.
Int Sch Res Notices. 2017 Aug 15;2017:1320684. doi: 10.1155/2017/1320684. eCollection 2017.
In patients with spinal metastatic disease, survival prognosis is a key consideration in selection for surgery and determining the extent of treatment. Individual survival prediction however remains difficult. We sought to validate the prognostic accuracy of seven preoperative scoring systems.
61 patients surgically treated for spinal metastases were retrospectively reviewed. Preoperative scores were calculated for Tokuhashi, Revised Tokuhashi, Bauer, Modified Bauer, Sioutos, Tomita, and van der Linden scoring systems. Prognostic value was determined by comparison of predicted and actual survival.
The Revised Tokuhashi and Modified Bauer scoring systems had the best survival predictive accuracy. Rate of agreement for survival prognosis was the greatest for the Modified Bauer score. There was a significant difference in survival of the prognostic groups for all but the van der Linden score, being most significant for the Revised Tokuhashi, Bauer, Modified Bauer, and Tomita scoring systems ( ≤ 0.001).
Overall, the scoring systems are accurate at differentiating patients into short-, intermediate-, and long-term survivors. More precise prediction of actual survival is limited and the decision for or against surgery should never be based on survival prognostication alone but should take into account symptoms such as neurological deficit or pain from pathological fracture and instability.
在脊柱转移性疾病患者中,生存预后是手术选择和确定治疗范围的关键考虑因素。然而,个体生存预测仍然困难。我们试图验证七种术前评分系统的预后准确性。
对61例接受脊柱转移瘤手术治疗的患者进行回顾性分析。计算Tokuhashi、修订版Tokuhashi、Bauer、改良版Bauer、Sioutos、Tomita和van der Linden评分系统的术前评分。通过比较预测生存和实际生存来确定预后价值。
修订版Tokuhashi和改良版Bauer评分系统具有最佳的生存预测准确性。改良版Bauer评分的生存预后一致性率最高。除van der Linden评分外,所有预后组的生存均存在显著差异,修订版Tokuhashi、Bauer、改良版Bauer和Tomita评分系统差异最为显著(≤0.001)。
总体而言,评分系统在将患者区分为短期、中期和长期幸存者方面是准确的。对实际生存的更精确预测有限,手术与否的决定绝不应仅基于生存预后,而应考虑神经功能缺损或病理性骨折及不稳定引起的疼痛等症状。